e-Pharma & Social...
Follow
8.0K views | +11 today
e-Pharma & Social Media
Your new post is loading...
Your new post is loading...
Scooped by Antoine POIGNANT, MD
Scoop.it!

Formation Marketing santé à l'heure du digital - Organisme de formation professionnelle continue - Les Echos Formation

Formation Marketing santé à l'heure du digital - Organisme de formation professionnelle continue - Les Echos Formation | e-Pharma & Social Media | Scoop.it
La formation Un format unique : training en réel sur IPad !, réalisable aussi en intra-entreprise , vous permettra de - Optimiser sa stratégie digitale et déterminer les facteurs clés de succès : e-patients, promotion, datas, ROI...
- Connaître les meilleures pratiques de e-detailing et de marketing multicanal avec des...
Antoine POIGNANT, MD's insight:

Formation exclusive MEDITAILING LES ECHOS 

Format innovant : iPad prêté

Entièrement interactive : thèmes digital santé et pharma

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Health innovations, mhealth, digital ...
Scoop.it!

How big data is beginning to change how medicine works

How big data is beginning to change how medicine works | e-Pharma & Social Media | Scoop.it
The medical community can leverage big data analytics for many kinds of insights --- from determining the frequency of certain diseases in a given population to optimizing treatment protocols to ve...

Via Philippe Loizon, Clara Hamelin
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Buzz e-sante
Scoop.it!

Médicaments : Macron ferme la porte à la vente en supermarchés

Médicaments : Macron ferme la porte à la vente en supermarchés | e-Pharma & Social Media | Scoop.it
Il faudra encore attendre pour acheter de l’aspirine dans les supermarchés. Alors que 77 % des Français se déclarent prêts à acheter...

Via Rémy TESTON
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Pensez vous que le marché de la santé connectée...

Pensez vous que le marché de la santé connectée... | e-Pharma & Social Media | Scoop.it
J’ai lu avec attention l’interview d’Alexis Normand du 22 septembre dans Vision Marketing.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Digital World of Pharma - #Esanté - #Ehealth
Scoop.it!

Novartis Investing in $49 Billion mHealth market - Healthcare Social Media India

Novartis Investing in $49 Billion mHealth market - Healthcare Social Media India | e-Pharma & Social Media | Scoop.it
Novartis currently has 13 iPhone apps in Apple's App Store, and nine of them are designed for patients and consumers. Some, like "Sickel Cell Iron Invaders (Novartis Investing in $49 Billion mHealth...

Via Pharmacomptoir / Corinne Thuderoz
more...
Debbie Irwin's curator insight, September 28, 8:52 AM

It's all about patients as partners....

Scooped by Antoine POIGNANT, MD
Scoop.it!

Le Leem lance la plateforme d’échange Talents de patients

Le Leem lance la plateforme d’échange Talents de patients | e-Pharma & Social Media | Scoop.it
Pour recueillir et rendre visible la diversité des témoignages de patients et leur inventivité, Les Entreprises du Médicament (Leem) ouvre une plateforme d’échange : Talents de patients.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Buzz e-sante
Scoop.it!

Social Media Rules: The FDA Crackdown

Social Media Rules: The FDA Crackdown | e-Pharma & Social Media | Scoop.it

Studies have shown that 60% of Americans turn to the internet for medical advice. It’s obvious how social media naturally seems like another method pharmaceutical companies can quickly and easily advertise to consumers. Are pharmaceutical companies alone in trying to tap into our unconscious? Would you be surprised if I told you that you could be inadvertently perpetuating such behavior?  

The U.S. is one of the few countries that permits direct-to-consumer advertising of pharmaceuticals. We’ve all see the ads that ramble on about all the potential risks and side effects associated with various medications. No doubt you’ve probably been bombarded with flashy sidebars on the internet promoting one medication or another — some creepily relevant to our own medical conditions. As social media became a part of life for many of us, pharmaceutical companies were quick to exploit the medium. Platforms like Twitter are free to operate and far-reaching. Only until recently has there been a greater effort to regulate the content being disseminated to the public.

In this day and age, Big Pharma might not be quite as cavalier as you might expect. A quick search on Twitter says it all. Almost every major drug company has a verified Twitter account. While companies are generous in providing general medical knowledge or the update here or there that says the company is actively researching condition X, seldom do you find anything plugging a specific product.

Direct-to-consumer advertising on social media has revealed many challenges. Sometimes 140 characters simply isn’t enough to convey all the benefits let alone the black box warnings a drug may possess. The “Twitterverse” is an international community, and messages applicable to one population could wrongfully passed on to another. Some medications banned by one country may be promoted by individuals and corporations of another country. In fact, Glaxo Smith-Kline and AstraZeneca reportedly have disclaimers on their Facebook sites saying that information is “intended for US residents/consumers only.”

But how often are pharmaceutical companies really harping on their own products on Twitter? More likely than not, individuals are weighing in with their micro-reviews on Twitter. Some would argue that these posts could impact consumers. Bad experiences often motivate people to say something. What about the positive reviews? Who is really behind the tweets gushing about Medication XYZ?

So far, individuals aren’t being held accountable for claims they make. Should the FDA as individuals to report their disclosures? Should the FDA be verifying all social media posts that mention a drug? Something tells me there no room in the FDA budget for this. Others would go as far as to argue that this violates the first amendment.

In June 2014, the FDA released suggested guidelines to regulate social media posts by drug companies. Essentially for every post claiming benefit of a certain medication, the FDA is demanding equal reporting of risks and a link to more information to go with it. Sounds impossible to squeeze all that into 140 characters, and perhaps it these guidelines were meant to deter drug companies from using social media altogether to promote their products.

Let’s take a step back to ask ourselves a few questions:

Do you think the FDA is being fair to drug companies, or should we be hearing about the risks/benefits of toilet paper or have the nutrition facts be mandated for a tweet promoting candy bars? Do you think such regulations are resulting in adverse effects by deterring some individuals from learning about some medications? As mentioned earlier, should individuals be subjected to the same rules? Should all our tweets be regulated as potential advertisement for whichever product is mentioned?

To read the other posts in Austin Chiang’s Healthcare & Social Media series, click here.

 


Via Plus91, Rémy TESTON
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Domotique, robotique et objets connectés sur le Net
Scoop.it!

Deux stars de la santé connectée confirment avoir été embauchées par Apple

Deux stars de la santé connectée confirment avoir été embauchées par Apple | e-Pharma & Social Media | Scoop.it
Nous vous en parlions en avril dernier : une rumeur affirmait que Divya Nag, véritable de star montante de 22 ans dans le domaine des objets connectés à destination du domaine médi...

Via Mau
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques : les défis de la transformation digitale

Laboratoires pharmaceutiques : les défis de la transformation digitale | e-Pharma & Social Media | Scoop.it
Par sa dimension systémique, la révolution numérique induit des bouleversements majeurs au sein des entreprises. Avec la même force de...
Antoine POIGNANT, MD's insight:

Pour les laboratoires pharmaceutiques, au-delà de la “simple” digitalisation des actions et de la relation client, comment -et surtout pourquoi- élaborer une transformation qui ancre véritablement le digital dans toutes les dimensions du modèle d’affaires ? Quels enseignements tirer de secteurs plus « digitalisés » que la pharmacie ou dont le business model a déjà été disrupté ? Quelles sont les meilleures pratiques mises en place par la pharma  ?


Les big techs (Google, Apple, Samsung…) sont-ils vraiment  les futurs leaders mondiaux de la santé ? Quels sont leurs atouts ? Quelles sont leurs avancées stratégiques les plus récentes dans le domaine de la santé digitale ? Pourquoi entrent-ils sur le marché des bio-médicaments ? Comment veulent-ils disrupter le marché de la santé ?

more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Buzz e-sante
Scoop.it!

Apple needs healthcare and medical tech companies to help create reasons to wear their devices

Apple needs healthcare and medical tech companies to help create reasons to wear their devices | e-Pharma & Social Media | Scoop.it

Apple is trying create 'an iPod experience' in healthcare driven by its wearables, but Apple's wearables need to do things significant enough to persuade health consumers to carry their products around with them.


Via Andrew Spong, Rémy TESTON
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Agence TROUBAT
Scoop.it!

Apple's Innovation Secret: Bad Ideas

Apple's Innovation Secret: Bad Ideas | e-Pharma & Social Media | Scoop.it
In the history of bad ideas, becoming a pirate ranks near the top. Pirates rarely die old, and hardly go quietly. Blackbeard, perhaps the most famous Caribbean marauder of the 18th century, died of

Via EuroHealthNet
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques et transformation digitale #hcsmeufr

Laboratoires pharmaceutiques et transformation digitale #hcsmeufr | e-Pharma & Social Media | Scoop.it
La transformation digitale vecteur de croissance et de création de valeur : web casting, web conference, serious games, apps, flashcodes, santé connectée,
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Pharma Hub
Scoop.it!

Google Fit : la nouvelle plateforme santé de Google

Google Fit : la nouvelle plateforme santé de Google | e-Pharma & Social Media | Scoop.it

 Depuis Internet, il sera bientôt possible de jeter un coup d'oeil sur les données relatifs à sa santé grâce à un nouveau service Google.


Via Philippe Marchal/Pharma Hub
Antoine POIGNANT, MD's insight:

#quantifiedself #google #ehealth

more...
Jim Murphy's curator insight, June 17, 9:42 AM

@Google... êtes-vous sérieux cette fois?

Rescooped by Antoine POIGNANT, MD from IOT - CONNECTED DEVICES - QUANTIFIEDSELF by PHARMAGEEK
Scoop.it!

Le Dr Eric Couhet, notre médecin connecté, sur France 2 !

Le Dr Eric Couhet, notre médecin connecté, sur France 2 ! | e-Pharma & Social Media | Scoop.it
Eric Couhet, le médecin de brousse devenu médecin de campagne puis, en 2 ans, le médecin référence de la e-santé, était interviewé il y a une quinzaine de jours dans son cabinet par l'équipe de Lau...

Via Lionel Reichardt / le Pharmageek
more...
Jerome Leleu's curator insight, October 20, 2:15 AM

ajouter votre point de vue ...

Scooped by Antoine POIGNANT, MD
Scoop.it!

Cette boîte détecte des dizaines de cancers avec une simple goutte de sang

Cette boîte détecte des dizaines de cancers avec une simple goutte de sang | e-Pharma & Social Media | Scoop.it
Voilà une invention qui pourrait bien révolutionner l'oncologie : Miriam est un dispositif permettant de détecter des dizaines de cancers différents à l'aide d'un simple échantillon de sang. Inventé par une équipe de chercheurs en microbiologie, d'entrepreneurs et de data scientists, Miriam n'est pour l'instant qu'en phase de tests, mais les résultats sont prometteurs et pourraient permettre de détecter l'apparition de cancers bien plus tôt qu'à l'accoutumée. Pour détecter les cancers, le prototype étudie des biomarqueurs, les microARN. Pendant de longues années, les scientifiques ont pensé que ces ARN n'étaient présents que dans les cellules, comme intermédiaires indispensables à la synthèse des protéines. Il s'avère qu'ils sont également présents dans le sang. Grâce au dispositif, les chercheurs analysent en une heure à peine le taux et le type d'ARN présent dans l'échantillon de sang du patient, ils envoient ensuite les résultats sur un serveur cloud, qui va comparer les données avec celles de cas déjà référencés de personnes atteintes de cancer.C'est une biologiste grecque, Fay Christodoulou, qui est à l'origine de cette invention. Elle travaillait déjà sur l'ARN depuis plusieurs années lorsqu'elle décide de rejoindre un incubateur de la Silicon Valley. Là-bas, elle rencontre des scientifiques du monde entier et monte une équipe de recherche qui aboutira sur la création de la start-up Miroculus et aujourd'hui sur le projet Miriam.Crédit Photo : Miroculus
Antoine POIGNANT, MD's insight:
#disruption #innovation #rechclin #pharmasuccess
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Formation Marketing santé à l’heure du digital – Organisme de formation professionnelle continue – Les Echos Formation

Formation Marketing santé à l’heure du digital – Organisme de formation professionnelle continue – Les Echos Formation | e-Pharma & Social Media | Scoop.it
La formation Un format unique : training en réel sur IPad !
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Mobile Health: How Mobile Phones Support Health Care
Scoop.it!

Five Expectations For Physicians About The Future of Medicine

Five Expectations For Physicians About The Future of Medicine | e-Pharma & Social Media | Scoop.it

Five Expectations For Physicians About The Future of Medicineby Bertalan Meskó (MD, PhD) on September 25, 2014

The waves of technological changes coming towards us will generate new possibilities as well as serious threats to medicine and healthcare. Every stakeholder must prepare for these changes in order to reach a balance between using disruptive technologies in medicine and keeping the human touch.

I remain confident that it is still possible to establish that balance and there are reasons not only for patients but also for physicians to look forward to the next few years in medicine. Here are 5 of them.

 

1) Finally focus on patients

Technology is not against physicians and algorithms are not designed to replace them. Instead, by using efficient and simple technologies in the practice, physicians will finally have time and energy to focus on the patients.

Looking into their eyes while inputting data with augmented reality (Google Glass or digital contact lenses); listening to patients instead of trying to find the right information (as IBM Watson provides that already); and having access to all the devices that are needed to provide a good care (smartphones serving as biosensor packages). What is it if not a great prospect?

 

2) Avoid burning out

With supercomputers being used in medical decision making; physicians having skills related to digital literacy; using intuitive IT solutions that make it simple to input, export and move around data just like how children today use touchscreen devices; and getting access to the medical information they actually need, hours can be saved every week.

With less effort and time, they will be able to provide more care for their patients. This way, patient reward becomes an essential part again in the process of practicing medicine helping caregivers avoid burning out.

 

3) Use data that patients collect

The wearable revolution in health peaking this year gives patients the chance to take care of their own health, thus measure health parameters that have only been available and accessible in the ivory tower of medicine.

By bringing this data to the doctor visit, they can save time and effort, moreover, a true partnership between them can be established. As devices become better, cheaper and more efficient, physicians can soon start encouraging their patients to measure parameters relevant to their health and the results will be discussed and used during the next visit.

 

4) Crowdsource, crowdfund and crowdsolve

With the advances of social media and technologies that give access to these channels, no medical professional should feel alone when dealing with a complicated medical problem of challenge.

If information is needed, it can be crowdsourced; if funding is needed for a new project; it can be crowdfunded; and when a real medical solution is needed, they can find that through an inter-connected network of experts, resources and services.

 

5) Share responsibility with patients

Although it is now the responsibility of physicians to become the guides for their patients online (that requires new skills), by empowering them, actually responsibility can finally be shared. Medical professionals don’t have to make decisions alone, but in a close partnership with the patient.

But for this, every stakeholder must start preparing in time.


Via Emmanuel Capitaine , Celine Sportisse, dbtmobile
more...
Jerome Leleu's curator insight, September 30, 2:02 AM

ajouter votre point de vue ...

Scooped by Antoine POIGNANT, MD
Scoop.it!

Novartis named digital pharma company of the year - PMLiVE

Novartis named digital pharma company of the year - PMLiVE | e-Pharma & Social Media | Scoop.it
Antoine POIGNANT, MD's insight:

#digiitalpride #novartis

more...
EuroHealthNet's curator insight, September 26, 11:59 AM

#novartis #digitalpride #digital

Scooped by Antoine POIGNANT, MD
Scoop.it!

E-santé : une lenteur de déploiement inquiétante.

E-santé : une lenteur de déploiement inquiétante. | e-Pharma & Social Media | Scoop.it
La lenteur du déploiement de la e- Santé en France devient inquiétante, alors que les impératifs économiques sont déjà là. La digitalisation de la santé est pourtant certainement l’une des solutions les plus radicales à cette hémorragie financière.
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from Ma santé et le digital francophone
Scoop.it!

Is the Healthcare Industry Digitally Fit? Our Survey #hcsmeu

Digital technologies are altering the very fabric of the traditional healthcare delivery model. Consumers are actively embracing digital tools to take charge o…

Via Plus91, Lionel Reichardt / le Pharmageek, Emmanuel Capitaine
more...
No comment yet.
Rescooped by Antoine POIGNANT, MD from le monde de la e-santé
Scoop.it!

Bayer’s Digital Health Accelerator Picks 5 Startups

Bayer’s Digital Health Accelerator Picks 5 Startups | e-Pharma & Social Media | Scoop.it
The pharmaceutical company grants valuable mentoring and $65,000 in seed money to each of the five companies, and gets up to 10 percent equity in return.

Via TUPINIER Arnaud, Lionel Reichardt / le Pharmageek, Jérôme Buisson, Fabrice Vezin
more...
Bettina Gifford's curator insight, September 9, 5:44 PM

Bayer and Merck leading the way?

Rescooped by Antoine POIGNANT, MD from le monde de la e-santé
Scoop.it!

Vade-mecum Télémédecine

Vade-mecum Télémédecine | e-Pharma & Social Media | Scoop.it
Le @CNOM édite un Vade-mecum : guide commenté pour la construction et la pratique de projets de #télémédecine. http://t.co/V9kboQRN2s

Via Emmanuel Capitaine , Fabrice Vezin
more...
No comment yet.
Scooped by Antoine POIGNANT, MD
Scoop.it!

Laboratoires pharmaceutiques et transformation digitale [étude]

Laboratoires pharmaceutiques et transformation digitale [étude] | e-Pharma & Social Media | Scoop.it

La transformation digitale est un vecteur de croissance et de création de valeur : web casting, web conference, serious games, apps, flashcodes, santé connectée, nouvel écosystème ...

Antoine POIGNANT, MD's insight:

La révolution numérique, en faisant entrer la société toute entière dans l’ère de l’information ubiquitaire,

induit des bouleversements majeurs au sein des entreprises. Avec la même force de disruption que la

révolution industrielle, elle transforme leur modèle d’affaires, leurs organisations, leur culture et leur mode

de management.

more...
EuroHealthNet's curator insight, September 6, 12:36 AM

Les big techs futurs géants de la pharma ?


Un membre du conseil d'administration du groupe suisse Roche vient ainsi de quitter ses fonctions pour se concentrer sur son poste de PDG de Calico, la société de Google dans la santé, qui vient tout juste d'annoncer son premier investissement en partenariat avec la société de biotechnologie AbbVie.


Novartis mène un partenariat avec Google pour une lentille cornéenne connectée qui mesure la glycémie...


Découvrez l'étude MEDITAILING / LES ECHOS ETUDES entièrement consacrée à la transformation digitales des laboratoires pharmaceutiques.

Rescooped by Antoine POIGNANT, MD from actualité pharma-biotech-santé
Scoop.it!

Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery

Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery | e-Pharma & Social Media | Scoop.it
Literally dozens of pharmaceutical companies have disappeared over the last 20 years, not just small companies, but major ones like Upjohn, Pharmacia, Searle, Warner-Lambert and Schering-Plough. They have disappeared for excellent business reasons. But as a result, at a time when there is an explosion in the understanding of the cause of diseases, industry contraction has resulted in fewer scientists pursuing these new insights. In the long term, that doesn’t benefit the world’s health.

Via Richard Meyer, Robert Courbé, Julia FRANCOIS-BOUET
Antoine POIGNANT, MD's insight:

En même temps on s'en doutait un peu, la finance ne fait pas l'invasion, l'inverse ?

#astrazeneca vs #pfizer

more...
No comment yet.